Ashokkumar B. Patel

Array ( [id] => 5149458 [patent_doc_number] => 20070049518 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-01 [patent_title] => 'Novel method of treatment of inflammatory skin conditions' [patent_app_type] => utility [patent_app_number] => 11/515373 [patent_app_country] => US [patent_app_date] => 2006-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 15689 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20070049518.pdf [firstpage_image] =>[orig_patent_app_number] => 11515373 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4580232 [patent_doc_number] => 07850994 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2010-12-14 [patent_title] => 'Xerogel films for the controlled release of pharmaceutically active molecules' [patent_app_type] => utility [patent_app_number] => 11/403335 [patent_app_country] => US [patent_app_date] => 2006-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 8043 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/850/07850994.pdf [firstpage_image] =>[orig_patent_app_number] => 11403335 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5112595 [patent_doc_number] => 20070196510 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-23 [patent_title] => 'Method for treating resistant hypertension' [patent_app_type] => utility [patent_app_number] => 11/509895 [patent_app_country] => US [patent_app_date] => 2006-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12072 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20070196510.pdf [firstpage_image] =>[orig_patent_app_number] => 11509895 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5149567 [patent_doc_number] => 20070049627 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-01 [patent_title] => 'Treating vulvodynia using prodrugs of GABA analogs' [patent_app_type] => utility [patent_app_number] => 11/507659 [patent_app_country] => US [patent_app_date] => 2006-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19585 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20070049627.pdf [firstpage_image] =>[orig_patent_app_number] => 11507659 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5000387 [patent_doc_number] => 20070043021 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-22 [patent_title] => 'Olanzapine analogs and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/502789 [patent_app_country] => US [patent_app_date] => 2006-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 53205 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20070043021.pdf [firstpage_image] =>[orig_patent_app_number] => 11502789 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4432869 [patent_doc_number] => 07897591 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-01 [patent_title] => 'Method of treating fatty liver disease' [patent_app_type] => utility [patent_app_number] => 11/997002 [patent_app_country] => US [patent_app_date] => 2006-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 22 [patent_no_of_words] => 7491 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/897/07897591.pdf [firstpage_image] =>[orig_patent_app_number] => 11997002 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5205611 [patent_doc_number] => 20070027093 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-01 [patent_title] => 'Anorectic' [patent_app_type] => utility [patent_app_number] => 11/495095 [patent_app_country] => US [patent_app_date] => 2006-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17803 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20070027093.pdf [firstpage_image] =>[orig_patent_app_number] => 11495095 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7988053 [patent_doc_number] => 08076321 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-12-13 [patent_title] => 'Compositions for treatment of systemic mastocytosis' [patent_app_type] => utility [patent_app_number] => 11/996081 [patent_app_country] => US [patent_app_date] => 2006-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 57 [patent_no_of_words] => 21132 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/076/08076321.pdf [firstpage_image] =>[orig_patent_app_number] => 11996081 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5205736 [patent_doc_number] => 20070027218 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-01 [patent_title] => 'Pharmaceutical compositions comprising higher primary alcohols and ezetimibe and process of preparation thereof' [patent_app_type] => utility [patent_app_number] => 11/489253 [patent_app_country] => US [patent_app_date] => 2006-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6328 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20070027218.pdf [firstpage_image] =>[orig_patent_app_number] => 11489253 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 345172 [patent_doc_number] => 07498359 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-03-03 [patent_title] => 'Composition and method for preventing recurrence of stroke' [patent_app_type] => utility [patent_app_number] => 11/486091 [patent_app_country] => US [patent_app_date] => 2006-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8653 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/498/07498359.pdf [firstpage_image] =>[orig_patent_app_number] => 11486091 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7503673 [patent_doc_number] => 08034801 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-11 [patent_title] => 'Analgesic agent' [patent_app_type] => utility [patent_app_number] => 12/309180 [patent_app_country] => US [patent_app_date] => 2006-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6194 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 151 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/034/08034801.pdf [firstpage_image] =>[orig_patent_app_number] => 12309180 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5564773 [patent_doc_number] => 20090137626 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'Pharmaceutical Composition Containing PPARgamma Agonist' [patent_app_type] => utility [patent_app_number] => 11/922670 [patent_app_country] => US [patent_app_date] => 2006-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3441 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20090137626.pdf [firstpage_image] =>[orig_patent_app_number] => 11922670 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5074871 [patent_doc_number] => 20070014846 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-18 [patent_title] => 'PHARMACEUTICAL COMPOSITIONS COMPRISING FENOFIBRATE AND ATORVASTATIN' [patent_app_type] => utility [patent_app_number] => 11/456566 [patent_app_country] => US [patent_app_date] => 2006-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 25267 [patent_no_of_claims] => 70 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20070014846.pdf [firstpage_image] =>[orig_patent_app_number] => 11456566 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5265614 [patent_doc_number] => 20090118299 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-07 [patent_title] => 'AGENT FOR PREVENTION OR TREATMENT OF GLAUCOMA' [patent_app_type] => utility [patent_app_number] => 11/995052 [patent_app_country] => US [patent_app_date] => 2006-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3932 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20090118299.pdf [firstpage_image] =>[orig_patent_app_number] => 11995052 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5392319 [patent_doc_number] => 20090209632 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-20 [patent_title] => 'Percutaneously Absorptive Ophthalmic Preparation Comprising Olopatadine' [patent_app_type] => utility [patent_app_number] => 11/988377 [patent_app_country] => US [patent_app_date] => 2006-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6784 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20090209632.pdf [firstpage_image] =>[orig_patent_app_number] => 11988377 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5851887 [patent_doc_number] => 20060235078 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-19 [patent_title] => 'Insulin secretion potentiator' [patent_app_type] => utility [patent_app_number] => 11/455813 [patent_app_country] => US [patent_app_date] => 2006-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 3761 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20060235078.pdf [firstpage_image] =>[orig_patent_app_number] => 11455813 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5603042 [patent_doc_number] => 20060293387 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-28 [patent_title] => 'Agent for lowering neutral fat concentration in blood' [patent_app_type] => utility [patent_app_number] => 11/455238 [patent_app_country] => US [patent_app_date] => 2006-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3341 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20060293387.pdf [firstpage_image] =>[orig_patent_app_number] => 11455238 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8591969 [patent_doc_number] => 08349845 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-08 [patent_title] => 'Thiazolopyrimidines for use in therapy' [patent_app_type] => utility [patent_app_number] => 11/917425 [patent_app_country] => US [patent_app_date] => 2006-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6071 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11917425 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5136543 [patent_doc_number] => 20070078172 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-05 [patent_title] => 'MAO-B INHIBITORS USEFUL FOR TREATING OBESITY' [patent_app_type] => utility [patent_app_number] => 11/424274 [patent_app_country] => US [patent_app_date] => 2006-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20157 [patent_no_of_claims] => 69 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0078/20070078172.pdf [firstpage_image] =>[orig_patent_app_number] => 11424274 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5392286 [patent_doc_number] => 20090209599 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-20 [patent_title] => 'Eye drop containing roflumilast' [patent_app_type] => utility [patent_app_number] => 11/921694 [patent_app_country] => US [patent_app_date] => 2006-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5111 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20090209599.pdf [firstpage_image] =>[orig_patent_app_number] => 11921694 [rel_patent_id] =>[rel_patent_doc_number] =>)